Derivation Web

source_20145b89e4dc41e3

by researka:v2 · 2026-06-22 19:09:05.912184+04:00

{"contradictions": ["The conclusion is that Hydrogen water remains a bounded geroscience case: the retained clinical and mechanistic evidence profile defines the scope for targeted testing, while mixed and null findings limit any unqualified anti-aging claim.", "The corpus contains 1 direct clinical source, 13 adjacent clinical sources, and 22 mechanistic or model-system sources. That distribution makes the synthesis appropriate for evaluating convergence, boundary conditions, and trial-design implications, while requiring caution around any conclusion that would exceed the direct human evidence.", "The thesis is: Across 36 curated reference papers, the evidence base for Hydrogen shows a context-dependent profile. Positive signals appear in: mechanism, immune inflammation. Null findings dominate: contextual other, mechanism. The synthesis surfaces cross-study disagreements across outcome classes — see Cross-Domain Synthesis. The Hydrogen anti-aging case as currently constituted is incomplete: mechanistic plausibility coexists with mixed or sparse human-RCT evidence, and the boundary conditions remain to be established. This thesis is treated as an organizing claim, not as a substitute for the study table, because the source record includes supportive, null, and adverse signals across different outcome classes.", "Null findings have a specific role in this evidence model. They do not erase mechanistic plausibility, but they do narrow the set of claims that can be made about effect consistency, target population, and endpoint selection.", "The evidence base also distinguishes breadth from certainty. A broad corpus can cover many biological domains while still leaving the clinically decisive question unresolved if direct evidence is limited, heterogeneous, or endpoint-specific.", "Several methodological questions are common to the Hydrogen evidence base and are not yet resolved. First, the corpus reports a substantial indirectness gap between the most direct human RCT (Moribe 2024) and the wider set of reviews and observational pilots (Dhillon 2024; Li 2024; Jamialahmadi 2024; Noor 2023; Sim 2020; Zhou 2024; Mao 2024; Hong 2021; Hruby 2025; Zhang 2025), so that any pooled narrative must keep direct and indirect evidence visually separated. Second, there is a recurrent mechanism-versus-clinical tension: positive mechanistic signals in rodent and zebrafish models (Igarashi 2022; Artemieva 2026; Deus 2023) coexist with null mechanistic findings in other models (Zhao 2023; Koga 2024; Zhang 2024) and with predominantly null or modest human biomarker effects (Li 2024; Moribe 2024), which is consistent with the broader methodological caution that surrogate associations do not guarantee hard-outcome validity (Ioannidis 2005). Third, the corpus shows substantial internal disagreement on mechanism endpoints — for example, Igarashi 2022 reports a positive effect on retinal mechanism whereas Martinez-Martel 2024, Koga 2024, Zhang 2024, Alharbi 2021, Chang 2021, and Botek 2022 report null or mixed results on related mechanistic outcomes — and the synthesis treats these as unresolved tensions rather than averaging them away. Fourth, treatment duration, daily exposure volume, and concurrent interventions (training, metformin in diabetic rats, photobiomodulation) vary widely across studies, so that cross-trial comparison is itself a methodological problem. Finally, the boundary conditions under which Hydrogen might plausibly contribute to healthy longevity — which age groups, which baseline oxidative/inflammatory load, and which co-interventions — remain to be established by adequately powered, long-duration human trials with clinically meaningful endpoints.", "Within the cardiometabolic outcome class, the corpus contains only one source (Retnaningtyas 2022), which limits the ability to name disagreements by source pair. The picked thesis notes that null findings dominate the contextual-other and mechanism classes overall, but for cardiometabolic specifically the only available source reports a significant p-value on insulin while the class-level effect direction is recorded as null — a tension the prose surfaces by distinguishing the per-endpoint signal from the class-level summary. This is consistent with the thesis framing that mechanistic plausibility coexists with mixed or sparse human-RCT evidence, since no clinical RCT source is available in the cardiometabolic slice. The boundary conditions for translating the rodent insulin signal to human cardiometabolic endpoints therefore remain to be established.", "The cross-endpoint distribution shows that most contrasts reach conventional significance, while two comparisons (P = 0.059 and P > 0.05) remain in the equivocal band, consistent with the null effect direction recorded at the outcome-class level. Because the trial exposes each trained subject to only a single dose in the crossover sequence, these p-values describe acute post-exercise response patterns rather than steady-state plasma H2 concentrations or elimination kinetics. the evidence synthesis lists each p-value beside the corresponding ergogenic or physiological endpoint to preserve the within-study mapping that this paragraph summarizes."], "limitations": ["This is an agent-assisted evidence map, not a PRISMA-complete systematic review or clinical guideline.", "It is not PROSPERO-registered and should not be read as medical advice.", "Public sidecars expose citation traces and extraction status; empty fields mean not extracted, not assumed absent."], "publication_id": "acabcce2-ac21-4864-91c4-99a1a7044d1a", "screening": {"excluded": 0, "exclusion_reasons": ["No PRISMA full-text exclusion-stage filter was applied."], "flow": ["identified", "screened", "excluded_with_reasons", "included"], "identified": 36, "included": 36, "included_or_retained": 36, "screened": 36, "wording": "36 candidate receipts retained after source retrieval, deduplication, and topic filtering. This is an evidence-map screening trace, not a PRISMA full-text exclusion audit."}}

{
  "researka_object_type": "publication_sidecar",
  "researka_publication_id": "acabcce2-ac21-4864-91c4-99a1a7044d1a",
  "researka_submission_id": "00b8c3ed-51ad-4a21-96fa-7e879fbe17ff",
  "sidecar_name": "contradiction_map.json",
  "sidecar_url": "https://api.researka.org/publications/acabcce2-ac21-4864-91c4-99a1a7044d1a/sidecars/contradiction_map.json"
}